Skip to main content
NCBI home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1989 Feb;82(2):91–92. doi: 10.1177/014107688908200212

Plasma and lipoprotein lipids and apolipoproteins AI, AII and B in patients with chronic airflow limitation.

C H Bolton 1, E Mulloy 1, J Harvey 1, L G Downs 1, M Hartog 1
PMCID: PMC1292001  PMID: 2494326

Abstract

Plasma and lipoprotein cholesterol and triglycerides, and plasma apolipoproteins AI, AII and B were compared in patients with chronic airflow limitation, and normal controls matched for body mass index. The controls were non-smokers, and free from respiratory disease. High-density lipoprotein (HDL) cholesterol concentration was significantly elevated in the patients, due mainly to a raised HDL2 cholesterol level. HDL triglyceride was significantly lower in the patients. All other lipids were not different from normal. Apolipoprotein AI levels were significantly raised in the patients but other apolipoproteins were unchanged. The changes found may account in part for the fact that patients with chronic airflow limitation have a lower incidence of atherosclerotic heart disease.

Full text

PDF
91

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chazan R., Droszcz W., Bobilewicz D., Maruchin J. E. Changes in plasma high density lipoproteins (HDL) levels after salbutamol. Int J Clin Pharmacol Ther Toxicol. 1985 Aug;23(8):427–429. [PubMed] [Google Scholar]
  2. Eyre J., Hammett F., Miller N. E. A micro-method for the rapid ultracentrifugal separation of human plasma high density lipoprotein subfractions, HDL2 and HDL3. Clin Chim Acta. 1981 Aug 10;114(2-3):225–231. doi: 10.1016/0009-8981(81)90395-8. [DOI] [PubMed] [Google Scholar]
  3. Hooper P. L., Woo W., Visconti L., Pathak D. R. Terbutaline raises high-density-lipoprotein-cholesterol levels. N Engl J Med. 1981 Dec 10;305(24):1455–1457. doi: 10.1056/NEJM198112103052406. [DOI] [PubMed] [Google Scholar]
  4. Kruszynska Y. T., Greenstone M., Home P. D., Cooke N. J. Effect of high dose inhaled beclomethasone dipropionate on carbohydrate and lipid metabolism in normal subjects. Thorax. 1987 Nov;42(11):881–884. doi: 10.1136/thx.42.11.881. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Lehtonen A., Viikari J., Sallinen V. P., Elo J. Effect of beta 2-adrenergic stimulation on serum lipids. Int J Clin Pharmacol Ther Toxicol. 1982 Nov;20(11):530–531. [PubMed] [Google Scholar]
  6. Lopes-Virella M. F., Stone P., Ellis S., Colwell J. A. Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem. 1977 May;23(5):882–884. [PubMed] [Google Scholar]
  7. Miller N. E., Hammett F., Saltissi S., Rao S., van Zeller H., Coltart J., Lewis B. Relation of angiographically defined coronary artery disease to plasma lipoprotein subfractions and apolipoproteins. Br Med J (Clin Res Ed) 1981 May 30;282(6278):1741–1744. doi: 10.1136/bmj.282.6278.1741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. NONKIN P. M., DICK M. M., BAUM G. L. MYOCARDIAL INFARCTION IN RESPIRATORY INSUFFICIENCY. Arch Intern Med. 1964 Jan;113:42–45. doi: 10.1001/archinte.1964.00280070044009. [DOI] [PubMed] [Google Scholar]
  9. Rosseneu M., Vercaemst R., Steinberg K. K., Cooper G. R. Some considerations of methodology and standardization of apolipoprotein B immunoassays. Clin Chem. 1983 Mar;29(3):427–433. [PubMed] [Google Scholar]
  10. Rosseneu M., Vinaimont N., Musliner T. A., Bernier D., Herbert P. N., Belpaire F. Immunonephelometry of apolipoprotein A-II in plasma. Clin Chem. 1984 Feb;30(2):234–237. [PubMed] [Google Scholar]
  11. Steinberg K. K., Cooper G. R., Graiser S. R., Rosseneu M. Some considerations of methodology and standardization of apolipoprotein A-I immunoassays. Clin Chem. 1983 Mar;29(3):415–426. [PubMed] [Google Scholar]
  12. Tisi G. M., Conrique A., Barrett-Connor E., Grundy S. M. Increased high density lipoprotein cholesterol in obstructive pulmonary disease (predominant emphysematous type). Metabolism. 1981 Apr;30(4):340–346. doi: 10.1016/0026-0495(81)90113-x. [DOI] [PubMed] [Google Scholar]
  13. Tokizawa M., Takizawa J., Nagano S., Takahashi T. [Serum high density lipoprotein cholesterol levels in patients with bronchial asthma]. Nihon Kyobu Shikkan Gakkai Zasshi. 1985 Jan;23(1):98–105. [PubMed] [Google Scholar]
  14. Ury H. K. Efficiency of case-control studies with multiple controls per case: continuous or dichotomous data. Biometrics. 1975 Sep;31(3):643–649. [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES